24 citations
,
November 2007 in “Journal of Investigative Dermatology Symposium Proceedings”
This article discusses using cosmetic hair products alongside medical treatments for hair conditions to enhance patient self-esteem and quality of life, without reporting new clinical results.
This review covers trichoscopy's role in diagnosing scalpdisorders, emphasizing its potential to improve clinical accuracy, but it reports no new clinical results.
1 citations
,
August 2023 in “arXiv (Cornell University)”
This study reports that deep learning models, particularly CNN and FCN, achieved high accuracy in diagnosing scalp and skin disorders, suggesting potential for improved diagnostic systems with further advancements.
1 citations
,
March 2024 in “Skin research and technology”
In this study, a modified Xception deep learning model achieved a 92% accuracy rate in diagnosing hair and scalpdisorders, significantly outperforming other models, suggesting AI could improve dermatological diagnostics' accuracy and accessibility.
January 2024 in “International Journal of Advanced Computer Science and Applications”
This review reports that while deep learning shows promise in diagnosing scalpdisorders from images, challenges remain with data quality and model interpretability, suggesting that integrating explainable AI techniques is crucial for building trust and facilitating clinical adoption.
The user experienced hair loss and used minoxidil, biotin shampoo, and supplements like biotin, zinc, fish oil, saw palmetto, and B vitamins, which initially stopped hair loss but did not promote regrowth. They suspect heat causes a dry, flaky scalp leading to hair loss and are considering using a supplementary shampoo and possibly finasteride.
Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.
Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.
Topical finasteride may reduce more scalp DHT but is seen as inconsistent and messy compared to oral finasteride. Users report mixed results with both forms, with some preferring oral for its convenience and consistent dosing, while others find topical effective but harder to apply.
A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.